Long
ADTX Breakout Stock Alert Update
BREAKOUT STOCK ALERT UPDATE
ADTX - ADiTx Therapeutics, Inc. - Common Stock
Initial Alert Price: $2.1
Price High: $6.73
% Gains/Losses: 220.48%
(+201% More Than Expected)
Potential Stop Loss: $6.3935
ADTX hit $6.73 providing a 180.42% Return on Investment from our initial trade alert on December 22nd, 2020 due to the release date being set for the AditxtScore Platform Immune Monitoring Platform on Feb. 1st, 2020. The initial application of the platform will be AditxtScore for Covid-19, which has been designed to provide a more complete assessment of an individual's infection and immunity status with respect to the SARS-CoV-2 virus. We're currently seeing some healthy pullback but expect this to continue to run as the stock is showing signs of reversing on the lower timeframes as of this message. Keep a close on eye on this moving forward and look forward for our Exit Strategy Alert if we see one fit for this trade at this time. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
ADTX - ADiTx Therapeutics, Inc. - Common StockInitial Alert Price: $2.1
Price High: $6.73
% Gains/Losses: 220.48%
(+201% More Than Expected)
Potential Stop Loss: $6.3935
ADTX hit $6.73 providing a 180.42% Return on Investment from our initial trade alert on December 22nd, 2020 due to the release date being set for the AditxtScore Platform Immune Monitoring Platform on Feb. 1st, 2020. The initial application of the platform will be AditxtScore for Covid-19, which has been designed to provide a more complete assessment of an individual's infection and immunity status with respect to the SARS-CoV-2 virus. We're currently seeing some healthy pullback but expect this to continue to run as the stock is showing signs of reversing on the lower timeframes as of this message. Keep a close on eye on this moving forward and look forward for our Exit Strategy Alert if we see one fit for this trade at this time. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.